Dyad Medical Joins NVIDIA Inception Program

June 14, 2019

Boston, Massachusetts—June 14, 2019—Dyad Medical, a deep learning medical image analytics company, announced that it has joined the NVIDIA Inception program, which is designed to nurture startups revolutionizing industries with advancements in AI and data science.
Dyad Medical develops clinical applications using artificial intelligence, aimed at enabling doctors to more efficiently and effectively interpret medical image content. Dyad Medical’s solutions will be offered in two spaces:
1. Research: where image interpretation is done off-line, post-image-acquisition.
2. In the clinic: to support treatment decision making. Inclusion in the NVIDIA Inception program will provide Dyad Medical with access to
leading-edge resources in artificial intelligence, deep learning and data science, enabling Dyad Medical to strengthen its deep learning expertise. Dyad Medical will also benefit from access to hardware grants, best-in-class training and more.

“We’re thrilled to join the exceptional list of startups in the NVIDIA Inception program, which supports our vision of streamlining medical image analysis and interpretation, reducing error rates and making image analysis more accessible,” said Ronny Shalev, cofounder and CEO of Dyad Medical. “Joining the program will help support our goal for expansion into new markets and help ensure our AI offering continues to be ahead of the curve.”
NVIDIA’s Inception program is a virtual accelerator program that helps startups during critical stages of product development, prototyping and deployment. Every Inception member gets a custom set of ongoing benefits, from hardware grants and marketing support to training with deep learning experts.

About Dyad Medical:
Dyad Medical is a pioneer in the development of deep learning architectures enabling quick and accurate medical image analysis and interpretation. With a platform developed by data scientists, machine learning practitioners, and medical experts, Dyad Medical is researching and developing analysis algorithms of images generated by a variety of data sources improving diagnostic accuracy. Dyad Medical was recently selected to participate in the 2019 MassChallenge Boston accelerator program representing the top 9% of applications from around the world, including 61 countries and 25 U.S. states. Find out more at www.dyadmed.com and follow us on Twitter and Linkedin.
Contact about this news:
Dyad Medical, Inc.
Ronny Shalev, PhD
e-mail: info@dyadmed.com
phone: 617-480-9569